Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation

INTRODUCTION: De novo C3 glomerulonephritis (C3GN) after transplant is uncommon. Although eculizumab has been used successfully in several cases, the response is heterogeneous, and treatment strategies remain undefined. The use of repository corticotropin in C3GN has not been described in the litera...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseer, Muhammad Saad, Singh, Ayush, Singh, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670034/
https://www.ncbi.nlm.nih.gov/pubmed/36751532
http://dx.doi.org/10.1159/000520387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670034/
https://www.ncbi.nlm.nih.gov/pubmed/36751532
http://dx.doi.org/10.1159/000520387

Ejemplares similares